Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
02/2007
02/27/2007US7183323 Sodium channel modulators
02/27/2007US7183292 Substituted pyrrolidine and related compounds
02/27/2007US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
02/27/2007US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants
02/27/2007US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy
02/27/2007US7183270 Cyclic derivatives as modulators of chemokine receptor activity
02/22/2007WO2006093547A3 Novel lipoxygenase inhibitors
02/22/2007WO2006002185A8 Chemical compounds
02/22/2007WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same
02/22/2007US20070043234 Use of functionalized onium salts as a soluble support for organic synthesis
02/22/2007US20070043088 Process for preparing lacidipine
02/22/2007US20070043080 Substituted anilinic piperidines as MCH selective antagonists
02/22/2007US20070043079 Heterocyclic compound containing nitrogen atom and use thereof
02/22/2007US20070042109 Conversion of amine- to carboxyl groups on solid surfaces
02/22/2007US20070041899 Radiolabelled substrates
02/21/2007EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
02/21/2007EP1754701A1 Sulfonyloxy derivatives
02/21/2007EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
02/21/2007EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals
02/21/2007EP1753722A2 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
02/21/2007EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
02/21/2007EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
02/21/2007EP1551798B1 Novel sulphones for inhibition of gamma secretase
02/21/2007EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007CN1918261A Anthracene derivative host having ranges of dopants
02/21/2007CN1918124A New pyridin-2-one compounds useful as inhibitors of thrombin
02/21/2007CN1918123A Extractive of marasmius androsaceus, derivative of piperidone, and appliction for preparing medication of anti high blood pressure
02/21/2007CN1918114A Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
02/21/2007CN1917873A Diurea derivatives
02/21/2007CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
02/21/2007CN1915974A Method for splitting Amlodipine
02/20/2007US7179922 Chemical compounds
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179820 Administering to an animal having ocular hypertension a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester
02/20/2007US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007CA2375225C Mutual salt of amlodipine and atorvastatin
02/15/2007WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
02/15/2007US20070037984 Biphenyl derivatives
02/15/2007US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction
02/15/2007US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
02/15/2007US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof
02/15/2007US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
02/15/2007CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/14/2007EP1752449A1 Pharmaceutical coposition
02/14/2007EP1444220B1 Compounds and method for the treatment of overactive bladder
02/14/2007EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
02/14/2007CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication
02/14/2007CN1914192A Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
02/14/2007CN1914152A New compounds, methods for their preparation and use thereof
02/14/2007CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/14/2007CN1911913A New neuropeptide YY5 receptor antagonists
02/14/2007CN1300112C Synthesis method of N-benzyl-4-piperidyl formaldehgde
02/13/2007US7176950 Catalyst components, process for their preparation and their use as catalyst components in polymerization of olefins
02/13/2007US7176318 Processes for the production of fexofenadine
02/13/2007US7176316 Amino-piperidine derivatives
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176222 Contacting a base with an enantiomerically pure hydroxyl group containing compound, reacting the product with a nitro, fluoro-containing benzene compound, reducing the product to the corresponding amine
02/13/2007US7176218 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
02/13/2007US7176210 Cannabinoid receptor ligands and uses thereof
02/13/2007US7176204 Substituted carboxylic acid derivatives
02/13/2007US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved
02/13/2007US7175872 Food sweetness or saltiness enhancers; such as N(1-carboxyethyl)-6-hydroxymethyl-pyridinium-3-olate; synthesis from amino acid or peptide with furan derivative
02/13/2007CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
02/13/2007CA2220649C 4-hydroxy-piperidine derivatives
02/08/2007WO2007016358A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
02/08/2007WO2007015805A1 1-amino linked compounds
02/08/2007WO2007015668A1 New salt iii
02/08/2007WO2007015667A1 New salt ii
02/08/2007WO2007015666A1 New salt i
02/08/2007WO2007015664A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.
02/08/2007WO2007015588A1 Piperidine derivative as tachykinin receptor antagonist
02/08/2007WO2007015567A1 Cyclic amine compound
02/08/2007WO2007015052A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil
02/08/2007US20070032656 Use of metal complex compounds as oxidation catalysts
02/08/2007US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis
02/08/2007US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
02/08/2007US20070032524 Diphenylmethyl compounds useful as muscarinic receptor antagonists
02/08/2007US20070032523 Chemical compounds
02/08/2007US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
02/08/2007US20070032475 Novel compounds useful for bradykinin B1 receptor antagonism
02/08/2007CA2617406A1 New salt iii
02/08/2007CA2617404A1 New salt ii
02/08/2007CA2617403A1 New salt i
02/08/2007CA2617256A1 Cyclic amine compound
02/08/2007CA2617165A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil
02/08/2007CA2617127A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.
02/08/2007CA2616184A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators
02/07/2007EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
02/07/2007EP1749032A1 Alkoxyamines containing a radically polymerizable group
02/07/2007EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
02/07/2007EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists
02/07/2007EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin